157 related articles for article (PubMed ID: 6248602)
1. Lymphocyte reactivity in infectious mononucleosis.
ten Napel CH; The TH
J Infect Dis; 1980 Jun; 141(6):716-23. PubMed ID: 6248602
[TBL] [Abstract][Full Text] [Related]
2. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
Nikoskelainen J; Ablashi DV; Isenberg RA; Neel EU; Miller RG; Stevens DA
J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224
[TBL] [Abstract][Full Text] [Related]
3. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
Wasik M; Myc A; Matej H; Rudzka L
Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
Lewin N; Aman P; Akerlund B; Gustavsson E; Carenfelt C; Lejdeborn L; Klein G; Klein E
Immunol Lett; 1990 Oct; 26(1):59-65. PubMed ID: 2177451
[TBL] [Abstract][Full Text] [Related]
5. Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens.
Periman P; Levine PH; Ablashi DV; Royston I
Int J Cancer; 1977 Oct; 20(4):506-11. PubMed ID: 199544
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.
Szigeti R; Timar L; Weiland O; Henle W; Henle G; Hennessy K; Kieff E; Sulitzeanu D; Dillner J; Klein G
Clin Immunol Immunopathol; 1986 Dec; 41(3):342-50. PubMed ID: 3022972
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
8. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
Jondal M
Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
[TBL] [Abstract][Full Text] [Related]
9. Relationship of in vitro immune responses to Epstein-Barr herpesvirus and severity of infectious mononucleosis.
Goldstein K; Lai PK; Lightfoote M; Andrese AP; Fuccillo D; Connor RJ; Levine PH
Infect Immun; 1980 Sep; 29(3):945-52. PubMed ID: 6253402
[TBL] [Abstract][Full Text] [Related]
10. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
[TBL] [Abstract][Full Text] [Related]
11. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
13. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
Sauerbrei A; Sprössig M; Wutzler P; Färber I; Schweizer H; Swoboda R; Wilke J
Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):170-4. PubMed ID: 6191167
[TBL] [Abstract][Full Text] [Related]
14. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
Al Tabaa Y; Tuaillon E; Jeziorski E; Ouedraogo DE; Bolloré K; Rubbo PA; Foulongne V; Rodière M; Vendrell JP
J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200
[TBL] [Abstract][Full Text] [Related]
15. [Immunologic indexes, enzyme status of lymphocytes and functional activity of blood neutrophils in children with infectious mononucleosis caused by Epstein-Barr virus].
Kurtasova LM; Tolstikova AE; Savchenko AA
Vestn Ross Akad Med Nauk; 2013; (7):42-6. PubMed ID: 24340961
[TBL] [Abstract][Full Text] [Related]
16. Complement-dependent, Epstein-Barr virus-neutralizing antibody appearing early in the sera of patients with infectious mononucleosis.
Sairenji T; Sullivan JL; Humphreys RE
J Infect Dis; 1984 May; 149(5):763-8. PubMed ID: 6327851
[TBL] [Abstract][Full Text] [Related]
17. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
[TBL] [Abstract][Full Text] [Related]
18. Studies on the presence of antibodies to EB virus and other herpesviruses in normal children and in infectious mononucleosis.
Gergely L; Czeglédy J; Váczi L; Szabó B; Binder L; Szalka A
Acta Microbiol Acad Sci Hung; 1975; 22(2):75-82. PubMed ID: 164758
[TBL] [Abstract][Full Text] [Related]
19. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
Thorley-Lawson DA
J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.
Lang D; Vornhagen R; Rothe M; Hinderer W; Sonneborn HH; Plachter B
Clin Diagn Lab Immunol; 2001 Jul; 8(4):747-56. PubMed ID: 11427421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
